Joshua Brandstadter

University of Pennsylvania

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (9)

Ivan Maillard

Professor

University of Pennsylvania

UNITED STATES

View details

Mark Robinson

Professor

University of Zurich

SWITZERLAND

View details

Shanmuganathan Chandrakasan

Emory University School of Medicine

UNITED STATES

View details

Natalia Pikor

Assistant Professor

ETH Zürich

SWITZERLAND

View details

David C. Fajgenbaum

University of Pennsylvania

UNITED STATES

View details

Burkhard Ludewig

University of Zurich & ETH Zurich

SWITZERLAND

View details

Eric Perkey

University of Chicago Medicine

UNITED STATES

View details

Sandro Stoeckli

Head of Department

Kantonsspital St. Gallen

SWITZERLAND

View details

Sheila Pierson

University of Pennsylvania

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Joshua Brandstadter

Research Interests

Explore related searches

Contact this professor

Articles (10)

Early Notch signals from fibroblastic reticular cells program effector CD8+ T cell differentiation

Fibroblastic reticular cells form reactive myeloid cell niches in human lymph nodes

Characterizing the heterogeneity of Castleman disease and oligocentric subtype: findings from the ACCELERATE registry

Splenic fibroblasts control marginal zone B cell movement and function via two distinct Notch2-dependent regulatory programs.

Longitudinal, natural history study reveals the disease burden of idiopathic multicentric Castleman disease.

Castleman disease patients report mild COVID-19 symptoms and mount a humoral response to SARS-CoV-2 vaccination.

Immune-mediated thrombocytopenia and IL-6-mediated thrombocytosis observed in idiopathic multicentric Castleman disease.

Treatment Consistent with Idiopathic Multicentric Castleman Disease Guidelines is Associated with Improved Outcomes

Having it both ways: how STAT3 deficiency blocks graft-versus-host disease while preserving graft-versus-leukemia activity

Siltuximab administration results in spurious IL-6 elevation in peripheral blood.

Collaborators (9)

Ivan Maillard

Mark Robinson

Shanmuganathan Chandrakasan

Natalia Pikor

David C. Fajgenbaum

Burkhard Ludewig

Eric Perkey

Sandro Stoeckli

Sheila Pierson

Make your next move.